过去一年中添加的文章，按日期排序
Treatment patterns and survival outcomes of patients admitted to the intensive care unit due to immune-related adverse events of immune checkpoint inhibitors
L Lin, API Houwink, JM van Dieren… - Cancer …, 2024 - pubmed.ncbi.nlm.nih.gov
5 天前 - … Conclusion: The incidence of irAEs leading to ICU admission in patients treated
with ICI was low in this study. ICU mortality due to irAEs was low and a subset of this patient …
with ICI was low in this study. ICU mortality due to irAEs was low and a subset of this patient …
Combination therapy with immune checkpoint inhibitors and denosumab improves clinical outcomes in non-small cell lung cancer with bone metastases
Y Asano, N Yamamoto, S Demura, K Hayashi… - Lung Cancer, 2024 - Elsevier
6 天前 - … (rwPFS) from the initiation of ICI treatment were evaluated using the Kaplan-Meier
curve, and the incidence rate of immune-related adverse events (irAEs) was investigated. …
curve, and the incidence rate of immune-related adverse events (irAEs) was investigated. …
Toxicity-Induced Discontinuation of Immune Checkpoint Inhibitors in Metastatic Urothelial Cancer: 6-Year Experience from a Specialized Uro-Oncology Center
S Rodler, C Aydogdu, I Brinkmann, E Berg, R Kopliku… - Cancers, 2024 - mdpi.com
7 天前 - … Immune-related adverse events (irAEs) are … a patient’s treatment course, most
commonly in the first couple of months of treatment, but in some cases, even well after treatment …
commonly in the first couple of months of treatment, but in some cases, even well after treatment …
Pembrolizumab in an HIV-infected patient with glioblastoma
CA Yuen, S Bao, M Pekmezci, F Mo, XT Kong - Immunotherapy - pubmed.ncbi.nlm.nih.gov
7 天前 - … Our patient did not develop any opportunistic infections, immune-related adverse
events, … To our knowledge, this is the first reported case of a PLWH and glioblastoma treated …
events, … To our knowledge, this is the first reported case of a PLWH and glioblastoma treated …
Investigating risk factors and treatment options for severe, partially steroid responsive, and steroid-refractory checkpoint inhibitor pneumonitis
M Moodabagil, R Easterling, J Peng… - The …, 2024 - academic.oup.com
7 天前 - … in patients treated with immune checkpoint inhibitor therapy: ASCO … Management
of immunerelated adverse events in patients treated with immune checkpoint inhibitor therapy: …
of immunerelated adverse events in patients treated with immune checkpoint inhibitor therapy: …
[HTML][HTML] Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma
RJ Verheijden, FH Burgers, JC Janssen… - European Journal of …, 2024 - Elsevier
10 天前 - … association between immunosuppression for immune-related adverse events (irAEs)
and impaired survival in patients who received immune checkpoint inhibitors. Whether this …
and impaired survival in patients who received immune checkpoint inhibitors. Whether this …
Monitoring immunE DysregulAtion foLLowing Immune checkpOint-inhibitioN (MEDALLION): protocol for an observational cancer immunotherapy cohort study
A Gault, L Hogarth, KC Williams, A Greystoke, N Rajan… - BMC cancer, 2024 - Springer
10 天前 - … Checkpoint inhibitors (CPIs) are widely used in cancer treatment, with transformative
… risk of toxicity in the form of immune-related adverse events (IrAEs), which may be …
… risk of toxicity in the form of immune-related adverse events (IrAEs), which may be …
Clinical Outcomes of Immune Checkpoint Inhibitors in Unique Cohorts Underrepresented in Clinical Trials
NJ Shah, A Della Pia, T Wu, A Williams, M Weber… - Cancers, 2024 - mdpi.com
11 天前 - … [34] was used to capture immune-related adverse events (irAEs) types and grades.
Investigator-assessed real-world clinical outcomes were collected and included the following…
Investigator-assessed real-world clinical outcomes were collected and included the following…
Endocrine side effects of tumor treatment
J Braegelmann, D Führer, S Tan - Innere Medizin (Heidelberg …, 2024 - europepmc.org
11 天前 - … to deal with new adverse events (AE) … checkpoint inhibitors (ICI) causes the
loss of immune tolerance to the body's own tissue with the occurrence of endocrine immune-related …
loss of immune tolerance to the body's own tissue with the occurrence of endocrine immune-related …
Neurologic outcomes in people with multiple sclerosis treated with immune checkpoint inhibitors for oncologic indications
CM Quinn, P Rajarajan, A Gill, H Kopinsky, AB Wolf… - medRxiv, 2024 - medrxiv.org
11 天前 - … ” – T-cell expressed programmed cell death protein 1 (PD-1), PD-1 ligand (PD-L1), …
side effect of immune upregulation is the development of immune-related adverse events (…
side effect of immune upregulation is the development of immune-related adverse events (…